Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07768215 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
Secondary endpoints: details revised at 3 of 3 entries
Study description expanded, about 2 words
MinorStart date: Sep 17, 2026 to Sep 20, 2026v21
MinorStart date: Sep 16, 2026 to Sep 17, 2026v20
MinorStart date: Sep 15, 2026 to Sep 16, 2026v19
MinorStart date: Sep 14, 2026 to Sep 15, 2026v18
MinorStart date: Sep 10, 2026 to Sep 14, 2026v17
MinorStart date: Sep 9, 2026 to Sep 10, 2026v16
MinorStart date: Sep 8, 2026 to Sep 9, 2026v15
MinorStart date: Sep 7, 2026 to Sep 8, 2026v14
MinorStart date: Sep 6, 2026 to Sep 7, 2026v13
MinorStart date: Sep 3, 2026 to Sep 6, 2026v12
MinorStart date: Sep 2, 2026 to Sep 3, 2026v11
MinorStart date: Sep 1, 2026 to Sep 2, 2026v10
MinorStart date: Aug 31, 2026 to Sep 1, 2026v9
MinorStart date: Aug 30, 2026 to Aug 31, 2026v8
MinorStart date: Aug 27, 2026 to Aug 30, 2026v7
MinorStart date: Aug 26, 2026 to Aug 27, 2026v6
MinorStart date: Aug 25, 2026 to Aug 26, 2026v5
MinorStart date: Aug 24, 2026 to Aug 25, 2026v4
MinorStart date: Aug 23, 2026 to Aug 24, 2026v3
MinorStart date: Aug 20, 2026 to Aug 23, 2026v2
MinorStudy First Submitted
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This first-in-human pilot study will test an investigational miniature breathing device called the Hope inVent. The device is a small, single-use, in-line respirator that connects to a breathing tube and uses compressed oxygen to help move air in and out of the lungs. It has no moving parts and is designed to provide short-term breathing support in situations where standard ventilators may not be available, such as emergencies, disasters, battlefield settings, transport, or ventilator shortages.
The study will enroll up to 5 brain-dead organ donors who are already receiving mechanical ventilation at the Gift of Life Donor Care Center at the Hospital of the University of Pennsylvania. Donors will only be included after authorization for organ donation and research has been obtained through standard procedures. Donors who may donate lungs or who have significant lung disease will not be included.
During the study, investigators will briefly replace the standard ventilator with the Hope inVent device for up to 15 minutes. The standard ventilator will remain immediately available, and the donor will be continuously monitored by the clinical and research teams. Investigators will measure whether the device can maintain acceptable breathing measures, including oxygen level and carbon dioxide level. They will also record breathing pressures and tidal volume, which is the amount of air delivered with each breath. If the device does not perform as expected or if any safety concern occurs, the donor will be returned immediately to the standard ventilator.
There is no direct benefit to the organ donor. Information from this study may help determine whether this type of simple, low-cost breathing device could be useful for future patients who need emergency or short-term ventilator support when standard ventilators are not available.